586 related articles for article (PubMed ID: 25967740)
1. Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients.
Andrade P; Santos-Antunes J; Rodrigues S; Lopes S; Macedo G
J Gastroenterol Hepatol; 2015 Nov; 30(11):1591-5. PubMed ID: 25967740
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
[TBL] [Abstract][Full Text] [Related]
3. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
Belle A; Baumann C; Bigard MA; Zallot C; Gizard E; Guéant JL; Bronowicki JP; Peyrin-Biroulet L
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):877-81. PubMed ID: 26121376
[TBL] [Abstract][Full Text] [Related]
4. SEROCONVERSION ANALYSIS AFTER HABITUAL HEPATITIS B VACCINATION SCHEME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES.
Cunha IS; Silva TCD; Malluta ÉF; Scolaro BL; Velho PS; Stall J
Arq Gastroenterol; 2020; 57(1):69-73. PubMed ID: 32294738
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of anti-hepatitis B surface antigen titers after hepatitis B vaccination in patients with inflammatory bowel disease.
Gisbert JP; Villagrasa JR; Rodríguez-Nogueiras A; Chaparro M
Inflamm Bowel Dis; 2013 Mar; 19(3):554-8. PubMed ID: 23380936
[TBL] [Abstract][Full Text] [Related]
6. Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease.
Pratt PK; Nunes D; Long MT; Farraye FA
Dig Dis Sci; 2019 Jul; 64(7):2031-2038. PubMed ID: 30945037
[TBL] [Abstract][Full Text] [Related]
7. Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study.
Fiorino G; Peyrin-Biroulet L; Naccarato P; Szabò H; Sociale OR; Vetrano S; Fries W; Montanelli A; Repici A; Malesci A; Danese S
Inflamm Bowel Dis; 2012 Jun; 18(6):1042-7. PubMed ID: 21674732
[TBL] [Abstract][Full Text] [Related]
8. Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls.
Altunöz ME; Senateş E; Yeşil A; Calhan T; Ovünç AO
Dig Dis Sci; 2012 Apr; 57(4):1039-44. PubMed ID: 22147248
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.
Papa A; Felice C; Marzo M; Andrisani G; Armuzzi A; Covino M; Mocci G; Pugliese D; De Vitis I; Gasbarrini A; Rapaccini GL; Guidi L
J Crohns Colitis; 2013 Mar; 7(2):113-9. PubMed ID: 22464811
[TBL] [Abstract][Full Text] [Related]
10. Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab Therapy.
Pratt PK; David N; Weber HC; Little FF; Kourkoumpetis T; Patts GJ; Weinberg J; Farraye FA
Inflamm Bowel Dis; 2018 Jan; 24(2):380-386. PubMed ID: 29361083
[TBL] [Abstract][Full Text] [Related]
11. Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3).
Loras C; Gisbert JP; Saro MC; Piqueras M; Sánchez-Montes C; Barrio J; Ordás I; Montserrat A; Ferreiro R; Zabana Y; Chaparro M; Fernández-Bañares F; Esteve M;
J Crohns Colitis; 2014 Nov; 8(11):1529-38. PubMed ID: 25052345
[TBL] [Abstract][Full Text] [Related]
12. [Active hepatitis B vaccination in ulcerative colitis treated with azathioprine].
Hinrichsen H; Fölsch UR
Internist (Berl); 1999 Mar; 40(3):327-8. PubMed ID: 10205763
[No Abstract] [Full Text] [Related]
13. Prevalence of hepatitis-B viral markers in patients with inflammatory bowel disease in a hepatitis-B-endemic area: inadequate protective antibody levels in young patients.
Kim ES; Cho KB; Park KS; Jang BI; Kim KO; Jeon SW; Kim EY; Yang CH; Kim WJ;
J Clin Gastroenterol; 2014 Jul; 48(6):553-8. PubMed ID: 24162170
[TBL] [Abstract][Full Text] [Related]
14. Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease.
Hagihara Y; Ohfuji S; Watanabe K; Yamagami H; Fukushima W; Maeda K; Kamata N; Sogawa M; Shiba M; Tanigawa T; Tominaga K; Watanabe T; Fujiwara Y; Hirota Y; Arakawa T
J Crohns Colitis; 2014 Mar; 8(3):223-33. PubMed ID: 24011513
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease.
Gisbert JP; Villagrasa JR; Rodríguez-Nogueiras A; Chaparro M
Am J Gastroenterol; 2012 Oct; 107(10):1460-6. PubMed ID: 23034605
[TBL] [Abstract][Full Text] [Related]
16. Immune response to hepatitis B vaccination among people with inflammatory bowel diseases: A systematic review and meta-analysis.
Jiang HY; Wang SY; Deng M; Li YC; Ling ZX; Shao L; Ruan B
Vaccine; 2017 May; 35(20):2633-2641. PubMed ID: 28404358
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France.
Chevaux JB; Nani A; Oussalah A; Venard V; Bensenane M; Belle A; Gueant JL; Bigard MA; Bronowicki JP; Peyrin-Biroulet L
Inflamm Bowel Dis; 2010 Jun; 16(6):916-24. PubMed ID: 19885908
[TBL] [Abstract][Full Text] [Related]
18. Immunogenecity of hepatitis A and B vaccination in pediatric patients with inflammatory bowel disease.
Urganci N; Kalyoncu D
J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):412-15. PubMed ID: 23841120
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease.
Gisbert JP; Menchén L; García-Sánchez V; Marín I; Villagrasa JR; Chaparro M
Aliment Pharmacol Ther; 2012 Jun; 35(12):1379-85. PubMed ID: 22530631
[TBL] [Abstract][Full Text] [Related]
20. Factors for hepatitis B vaccination and abnormal liver function in Chinese patients with inflammatory bowel disease: a single center experience.
Leung WK; Liu KSh; Seto WK; Chan KH; Tong T; Yuen MF; Lai CL; Hung IF
J Dig Dis; 2013 Nov; 14(11):596-603. PubMed ID: 23870196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
